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Hexachlorobenzene (HCB) is a persistent environmental pollutant. The toxicity of HCB has been
extensively studied after an accidental human poisoning in Turkey and more recently it has been
shown that HCB has immunotoxic properties in laboratory animals and probably also in man. Oral
exposure of rats to HCB showed stimulatory effects on spleen and lymph node weights and
histology, increased serum IgM levels, and an enhancement of several parameters of immune
function. Moreover, more recent studies indicate that HCB-induced effects in the rat may be
related to autoimmunity. In Wistar rats exposed to HCB, IgM antibodies against several
autoantigens were elevated; in the Lewis rat, HCB differently modulated two experimental models
of autoimmune disease. Oral exposure of rats to HCB induces skin and lung pathology in the rat.
Recently several studies have been conducted to investigate whether these skin and lung lesions
can be related to HCB-induced immunomodulation, and these studies will be discussed in this
review. HCB-induced skin and lung lesions probably have a different etiology; pronounced strain
differences and correlation of skin lesions with immune parameters suggest a specific
involvement of the immune system in HCB-induced skin lesions. The induction of lung lesions by
HCB was thymus independent. Thymus-dependent T cells were not likely to be required for the
induction of skin lesions, although T cells enhanced the rate of induction and the progression of
the skin lesions. No deposition of autoantibodies was observed in nonlesional or lesional skin of
HCB-treated rats. Therefore, we concluded that it is unlikely that the mechanism by which most
allergic or autoimmunogenic chemicals work, i.e., by binding to macromolecules of the body and
subsequent T- and B-cell activation, is involved in the HCB-induced immunopathology in the rat.
Such a thymus-independent immunopathology is remarkable, as HCB strongly modulates
T-cell-mediated immune parameters. This points at a very complex mechanism and possible
involvement of multiple factors in the immunopathology of HCB. Key words: autoantibodies,
hexachlorobenzene, immunopathology, immunotoxicity, lung, rat, skin. - Environ Health
Perspect 107(suppl 5):783-792 (1999).
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In this review, following a short introduction
on the general properties and general toxicity
ofhexachlorobenzene (HCB), the role ofthe
immune system in HCB-induced toxicity is
discussed. The immunotoxic properties of
HCB were observed in several animal studies
performed after an accidental poisoning in
Turkey (described in detail in this article).
The presence of autoantibodies in rats
exposed to HCB, as well as clinical features
such as enlarged thyroid and rheumatoid
arthritis of the hands observed in victims
involved in the poisoning incident, prompted
the hypothesis that the immune system,




HCB (C6C16) is a chlorinated organic
compound used extensively as a fungicide for
the treatment ofseed grain but is prohibited
for such use in most countries since 1970.
HCB has been used directly and as a chemi-
cal intermediate in many industrial processes,
including applications as a fluxing agent in
aluminum smelting, as a peptizing agent in
the rubber industry, and in the manufacture
ofdye (1). Currently, considerable amounts
ofHCB are generated as waste byproducts of
several industrial processes and subsequently
emitted into the environment. Jacoffand
Scarberry (2) estimated that in the United
States over 4,000 tons ofHCB are generated
each year as a waste byproduct mainly from
the manufacture of chlorinated solvents.
HCB can be easily distributed through the
environment because of its volatility and
resistance to degradation. The long-distance
distribution ofHCB via the troposphere is an
especially important route oftransportation
(3). Because ofits chemical stability and high
persistence, HCB readily accumulates in food
chains (4,5). For example, a significant bio-
magnification has been reported in field
studies in natural aquatic ecosystems (6) and
in predatory birds (7). HCB is present in
human adipose tissue, breast milk, and blood
(8-10). The major source ofHCB exposure
of the general population today is as a
contaminant in the diet (11,12).
There is no published information on the
elimination half-life ofHCB in humans (12).
Studies in experimental animals have shown
that excretion of HCB occurs mainly via the
feces (13) and half-lives of 1 month in rats
and rabbits and 2.5-3 years in rhesus
monkeys have been reported (14). Studies in
a number of animal species showed that a
small portion ofingested HCB is metabolized
and the remainder is stored in adipose tissue
or excreted via the feces (15-17). Two major
metabolic pathways of HCB in the liver are
responsible for the metabolism ofHCB. In
the mercapturic acid pathway, conjugation of
HCB to glutathione leads to formation ofthe
urinary end product N-acetyl-S-(pen-
tachlorophenyl)-cysteine (PCP-NAC)
(18,19). In addition, HCB is degraded by
cytochrome P450-catalyzed oxidative dehalo-
genation to the end products pentachlorophe-
nol (PCP) and 1,4-tetrachlorohydroquinone
(TCHQ) (15,20).
GeneralToxicityofHCB
Porphyria is regarded as the major poten-
tial toxic manifestation of HCB in experi-
mental animals and man. An outbreak of
HCB-induced porphyria occurred in
Turkey in the 1950s and will be described
in detail in the next section. HCB-induced
hepatic porphyria is characterized by a defi-
ciency of the enzyme uroporphyrinogen
decarboxylase resulting in the accumulation
ofporphyrins in the liver and increased uri-
nary excretion ofhighly carboxylated por-
phyrins (21,22). Since the accidental
poisoning in Turkey, many attempts have
been made to induce hepatic porphyria by
administration of HCB to laboratory ani-
mals. The rat has been used in several studies
and many similarities have been observed
between clinical disease in humans and in
the rat (23,24). HCB-induced porphyria in
birds is also comparable to the disease in
mammals (25,26).
Laboratory animal studies revealed that
chronic exposure to HCB could induce liver-
cell tumors in rats and mice (27-29), renal
adenomas in rats (30), and liver-cell tumors,
haemangioendotheliomas, and thyroid
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adenomas in hamsters (31). HCB acts as a
promoter ofcancer in several studies (32,33).
Investigation ofthe cancer incidence among
people living in a small village in Spain that
was located near achlorinated solvents factory
revealed increased incidence ofthyroid neo-
plasms and soft-tissue carcinomas in males
(34). On the basis ofevidence for carcino-
genicity ofHCB to laboratory animals and
the limited information for carcinogenicity to
humans, the International Agency for
Research on Cancer has classified HCB as a
group 2B carcinogen (possibly carcinogenic
to humans) (35).
The reproductive effects of HCB have
been studied in several animal models.
Iatropolous et al. (36) demonstrated severe
changes in ovarian structure, consisting offol-
licular degeneration in primordial germ cells
and stratification ofthe epithelium, in rhesus
monkeys orally administered HCB. Similar
effects have been observed in cynomolgus
monkeys exposed to HCB via feed. However,
despite the changes in ovarian tissue, the lat-
ter monkeys were capable of producing
embryos after induction ofsuperovulation,
oocyte recovery, and maturation followed by
in vitro fertilization (37). Studies in super-
ovulated female Sprague-Dawley rats fed
HCB showed significant elevated serum prog-
esterone levels, whereas therewas no effect on
serum estradiol levels and uterine weight
(38). In a subsequent study in adult ovariec-
tomized Sprague-Dawley rats fed the same
doses of HCB, it was demonstrated that
HCB induces alterations in adrenal steroido-
genesis ofthe rat (39). The male reproduc-
tion system was affected only by repeated
exposure toveryhigh doses ofHCB (40,41).
In several animal studies, lactational
transfer of HCB has been shown to be
important in affecting fetus and nursing off-
spring. A four-generation study in Sprague-
Dawley rats showed maternal deaths and a
reduced fertility index at the two highest
dose levels ofHCB, whereas lower doses of
HCB caused increased stillbirths and
decreased pup survival (42). Mink appeared
to be particularly sensitive to the toxicity of
prenatal HCB exposure; a low dose ofHCB
resulted in reduced birth weights and
increased mortality (43,44). A recent study
among Turkish women exposed or not
exposed to HCB during the accidental poi-
soning in the 1950s showed an increased risk
of spontaneous abortion related to high
serum HCB levels but not restricted to
women with identifiable exposure (45).
Neurologic effects of HCB have been
reported in victims ofthe poisoning incident
in Turkey and in short-term as well as in
chronic exposure studies in various animal
species including rats, rabbits, and guinea
pigs (46). In adult Japanese quails fed diets
containing HCB, tremors have been
reported, but histology showed no pathology
ofthe central nervous system (25). Reported
neurotoxic effects in rats exposed to HCB are
hyper-excitability, tremors, weak legs, and
paresis (23,47). However, no indications for
histopathologic changes in the brain, spinal
cord, motor and sensory nerves, and skeletal
muscles have been found (48,49).
Accidental Human Poisoning
in Turkey
From 1955 to 1959, approximately
3,000-5,000 people in southeastern Turkey
who ingested HCB-treated seed grain devel-
oped a disease characterized by hepatic por-
phyria called porphyria turcica (50,51).
Porphyria turcica resembled porphyria
cutanea tarda, a disease ofdisturbed por-
phyrin metabolism manifested by cutaneous
lesions; patients showed bullous skin lesions,
mainly in sun-exposed skin areas that healed
with severe scars. The skin lesions were attrib-
uted to the toxicity ofphotochemically acti-
vated cutaneous porphyrins (52). Porphyria
turcica primarily affected children 6-16 years
ofage, with only 10% ofthe patients over 16
years ofage (53,54). In addition to the dis-
turbance in porphyrin metabolism and der-
matologic changes, other reported clinical
manifestations included hepatomegaly,
enlarged thyroid, splenomegaly, hyper-
pigmentation, hirsutism, and enlarged lymph
nodes. Victims also showed neurologic symp-
toms such as paresthesia, sensory shading,
"cogwheeling," and myotonia. Painless
arthritic changes ofthe hands were observed
in 36% ofthe children 6-16 years ofage, and
a follow-up study 3-5 years later revealed a
further increased incidence of 55% ofthese
children showingsuch changes (54,55).
Porphyria turcica was rare in victims less
than 4 years ofage. In these infants a condi-
tion called Pembe Yara has been described,
characterized by rose-red skin lesions on arms
and legs, enlarged livers, diarrhea, and fever.
There was a high mortality (> 95%) among
young children who were exposed to HCB
via the placenta or maternal milk (51,53,54).
These young children developed skin lesions
in the absence ofporphyria. The skin lesions
apparently did not resemble the porphyria-
related etiology ofthe bullous skin lesions
observed in the oldervictims ofthepoisoning
incident. In follow-up studies among204vic-
tims 25-30years after thepoisoningincident,
dermatologic abnormalities, neurologic symp-
toms, enlarged thyroid, and painless arthritis
ofthe hands still persisted (56,57). For these
clinical features an immune etiology is con-
ceivable, and such an etiology could also be
involved in the porphyria-independent skin
lesions of the children with Pembe Yara.
Therefore, several studies in laboratory
animals have been performed to elucidate the
immunotoxicproperties ofHCB.
Immunomodulation of HCB
Several experimental studies have been
performed to investigate the immune effects
ofHCB, with special emphasis on the func-
tional immune effects in mice and rats.
Whereas in the rat most assessed parameters
ofimmune function were enhanced after oral
exposure to HCB, in mice the reverse was
true; most assessed parameters of immune
function were suppressed after oral HCB
exposure. Tables 1 and 2 give a summary of
the reported immunotoxic effects ofHCB in
rats and mice. Our animal studies were
approved by an ethical committee of the
institute and conducted in accordance with
the GuidingPrincples in the UseofAnimals in
Toxicology (58). Briefly, rats were housed at
the Utrecht University animal facilities and
kept in pairs in filter-topped macrolon cages
on wood-chip bedding under standard condi-
tions (50-60% relative humidity, 12-hr
dark/12-hr light cyde). The animals had free
access to food andacidifiedwater.
HCB-Induced Immunomodulation
intheRat
Reported dose-related immune effects of
HCB in male and female Wistar rats are
increased spleen and lymph node weights;
increased total serum IgM, IgG, and IgA lev-
els; and increased peripheral blood neu-
trophilic and basophilic granulocytes and
monocytes (59-62). Histopathologic exami-
nation ofthespleen andlymph nodesshowed
increased extramedullary hemopoiesis in the
red pulp and hyperplasia ofB lymphocytes in
marginal zones and follicles ofthe spleen as
well as an increase in high endothelial venules
in the lymph nodes (49,50,59). Functional
assessment ofthe immune system showed no
significant effect ofHCB on the phagocytiz-
ing and killing capacity ofmacrophages as
shown by Listeria monocytogenes mortality
assay and clearance ofcolloidal carbon. In
addition, no effect ofHCB on cell-mediated
immunity, as measured by delayed-type
hypersensitivity and skin graft rejection, has
been observed. However, HCB induced a
stimulation ofhumoral immunity, as meas-
ured byincreasedprimaryandsecondaryIgM
and IgG responses to the thymus-dependent
antigen tetanus toxoid. In contrast, the
thymus-independent IgM response to
lipopolysaccharide (LPS) remained unchanged
(59,60,63).
Slight changes in humoral and pulmonary
cellular defenses have been observed in a
study that investigated the effect ofsingle or
multiple inhalation exposures to HCB (64)
in male Sprague-Dawley rats. Recently it was
shown that exposure of Wistar rats to
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Table 1. Summary ofthe immunotoxic effects of hexachlorobenzene in rats.
Parameter Study Dosea Effectb Reference
Peripheral neutrophilic and basophilic granulocytes, and monocytes Wistar 1000 1 (59)
Serum IgM levels Wistar, BN,cLewis,c 300", 450, 900, 1000 1 (59,61,62,72)
Serum lgG and IgE levels BN 450 1 (72)
Serum IgA levels Wistar 300d 1 (62)
Serum IgM against ssDNA, dsDNA, Wistar 500, 1000 1 (61)
rat lgG, phosphatidylcholine
Serum 1gM against ssDNA BN, Lewis 150e,450 (72)
Spleen and lymph nodeweights Wistar, BN, Lewis 150-2000f 1 (59,61,62,72)
Marginal zones and follicles ofspleen Wistar 500, 1000 1 (59,61)
Extramedullary hemopoiesis Wistar 500, 1000 1 (60,63)
High endothelial venules in lymph nodes Wistar, BN,C Lewisc 150, 450, 900, 1000 - (59,72)
[1-2 and IFN-ymRNA ofspleen cells Wistar 150,450 1 (65)
IL-2R mRNAofspleen cells Wistar 450 t (65)
Primaryand secondary IgM and lgG againsttetanus toxoid Wistar 1000 1 (59)
Mitogenic response ofspleen cells to ConA, PHA, and LPS Wistar 1000 1 (59)
Susceptibility toendotoxin (Escherichia coli) Wistar 1000 1 (59)
Natural killercell activity inthe lung Wistar 150,450 -1 (66)
Effect on the induction ofM9 Lewis 450 J1 (68)
Effect on severity and spontaneous regression of EAE9 Lewis 450 1 (68)
Prenatal and postnatal exposure
Peripheral eosinophilic and basophilic granulocytes Wistar 150 1 (60)
Serum IgM levels Wistar 4, 50,100,150 1 (60,63)
Serum lgG levels Wistar 50,150 1 (60)
Popliteal lymph nodeweight Wistar 20, 100 1 (63)
High endothelial venules in lymph nodes Wistar 4-150 1 (60,63)
Delayed-type hypersensitivity againstovalbumin Wistar 4, 100 1 (63)
Primary and secondary IgM and lgG againsttetanus toxoid Wistar 4, 20, 50, 150 1 (60,63)
Resistance to Trichinellaspiralishand Listeriamonocytogenes infection Wistar 150 - (60)
Abbreviations: AA, adjuvant arthritis; BN, Brown Norway; ConA, concanavalin A; dsDNA, double-stranded DNA; EAE, experimental allergic encephalomyelitis; HCB, hexachlorobenzene; IFN, interferon; IL,
interleukin, LPS, lipopolysaccharide; PHA, phytohemagglutin; ssDNA, single-stranded DNA. 'Dietary HCB concentration (mg/kg). Most experiments with adult rats were short-term exposure studies of3-4
weeks of HCB exposure. In the prenatal and postnatal studies, exposure started atdays 1-3 of pregnancy and was continued until pups were 5weeks of age. bSignificantly increased (T) ordecreased(.1)
as compared to control rats. ¶ewis and BN were exposed to 150 and 450 mg/kg HCB. 0Wistar rats were exposed to HCB for 13 weeks. 'Significant increase in Lewis exposed to 450 mg/kg HCB and BN
exposed to 150 and 450 mg/kg. In Wistar rats that received 450, 500, 900, 1,000, and 2,000 mg/kg HCB, and Lewis and BN that received 450 mg/kg, these effects were observed.9Lewis rats were
exposed to450 mg/kg HCBfor6weeks before investigation ofthedevelopment ofAA or EAE. the lgG response against T. spiraliswas increased.
150 and 450 mg/kg HCB dose dependently
increased the ability of concanavalin A
(ConA) to increase interleukin (IL)-2 and
interferon-y mRNA levels ofspleen cells,
whereas IL-2R mRNA was increased at
450 mg/kg HCB (65).
Pme alandpostnatalHCB exposure.
The developing immune system seems to be
particularly vulnerable to the immunotoxic
effects of HCB, as observed in two studies
investigating the prenatal and postnatal toxic-
ity ofHCB. In the first study, rats received 0,
50, or 150 mg/kg HCB starting at days 1-3
of pregnancy, which was continued during
lactation and after weaning until pups were
5 weeks ofage (60). In the 150-mg/kg group,
increased serum IgM and IgG levels and
increased numbers ofblood basophilic and
eosinophilic granulocytes were observed.
Histopathologically, focal accumulation of
alveolar macrophages in the lung and prolif-
eration ofhigh endothelial venules in lymph
nodes were observed. Immune function tests
showed decreased resistance to Trichinella
spiralis, as measured by ahigheryield ofmus-
de larvae, and to Listeria monocytogenes infec-
tion at the high-dose group only. In addition,
increased primary and secondary IgM and
IgG responses to tetanus toxoid in both dose
Table 2. Summaryof the immunotoxic effects of hexachlorobenzene in mice.
Parameter Study Dosea Effectb Reference
Primary and secondary plaque-forming response BALB/c 167 1 (74)
ofspleen cells to sheep red blood cells
Serum IgA levels BALB/c 167 - (74)
Susceptibility toendotoxin(Salmonella typhosa) BALB/c 167 1 (74)
Resistance to Malaria infection BALB/c 100, 167 1 (74,75)
Resistance to Leishmaniainfection BALB/c 5,100 .1 (75)
Resistance to mKSAtumorcells BALB/c 100 1 (76)
Resistance to EL-4tumorcells C57BL/6 100 -1 (76)
Resistance to P388 tumor cells DBA/2 5, 100 .1 (76)
Resistance to L1210 tumor cells DBA/2 5, 100 -L (76)
Natural killercell activity of spleen BALB/c 100 Jo (76)
Cytotoxic macrophage activityof the spleen BALB/c 5, 100 -1 (76)
Graft-versus-hostactivity ofthe spleen C57BL/6 167C -1 (78)
Resistance to mouse hepatitis virus BALB/c 167 -1 (77)
Resistance to encephalomyocarditis infection C57BL/6 150 1 (79)
Resistance to MCA sarcoma cells C57BL/6 150 1 (79)
CytotoxicT-lymphocyte activity ofspleen C57BL/6 15 1 (79)
Resistance to mouse hepatitis virus Athymic mice 167d >1 (77)
Prenatal exposure:
Delayed-type hypersensitivity response to oxazolone BALB/c mice 0.5, 5 1 (79)
Mixed-lymphocyte response ofspleen cells BALB/c mice 5 -1 (79)
Number ofsplenic Tcells BALB/c mice 0.5, 5 1 (79)
Numberofsplenic B cells BALB/c mice 0.5, 5 1 (79)
HCB, hexachlorobenzene. 'Dietary HCB concentration (mg/kg). Mostexperiments with adult mice were short-term exposure studies of
3-10weeks of HCB exposure. In the prenatal study,0, 0.5, or 5 mg HCB/kg maternal bodyweight was given daily in 0.3 g peanut but-
terand selected immune functions were measured in 45-day-old offspring. bSignificantly increased (1') or decreased (-1) ascompared
to control animals. 1'his parameter remained unaffected after3, 6, or 13 weeks of exposure and was onlydepressed after 37 weeks
of HCB exposure. In athymic micethis parameter was severelydepressed.
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groups as well as a significantly increased IgG
response to T spiralis infection in the high-
dose group were observed. There were no
effects of HCB on splenic clearance of
Listeria and colloidal carbon, skin graft rejec-
tion, mitogenic responses ofspleen and thy-
mus cells, and IgM responses to LPS. In the
second prenatal and postnatal toxicity study,
exposure to 0, 4, 20, or 100 mg/kg HCB
showed increased serum IgM levels, increased
numbers ofbasophilic peripheral granulocytes
in the high-dose group, and increased
popliteal lymph node weights in the 20- and
100-mg/kg group. Histopathologic changes
in lymph nodes and lung were similar to
those described in the first study. In contrast
to the first study, there were no effects of
4 and 20 mg/kg HCB on the resistance to
T spiralis. There was no significant increase
ofthe IgM and IgG response to ovalbumin,
whereas dietary levels as low as 4 mg HCB/kg
feed significantly increased delayed-type
hypersensitivity reactions to ovalbumin.
Primary and secondary IgM and IgG anti-
body responses to tetanus toxoid were
increased in the 4- and 20-mg/kg dose groups
(63). Moreover, a high mortality ofsuckling
pups ofmothers exposed to 100 mg HCB/kg
diet has been observed in the same study. No
effects were observed of natural killer cell
activity in spleens ofrats prenatally and post-
natally exposed to 4 and 20 mg/kg HCB were
observed. More recent findings, however,
showed that oral exposure ofadultWistar rats
to 150 and 450 mg/kg HCB for 6 weeks dose
dependently suppressed natural killer cell
activity in thelung (66).
ThymusDependenceofthe Immune
Effe ofHCB
The involvement ofthymus-dependent Tcells
in HCB-induced immune effects has been
investigated in male athymic (rnu/rnu) and
euthymic (+/rnu) Wistar rats 3-4 weeks ofage
exposed for 6 weeks to control diets or diets
containing 450 mg/kg HCB (67). It was
observed in this study that HCB-induced tox-
icity, as judged by effects on bodyweight and
liver effects, was more pronounced in athymic
rats than in euthymic rats exposed to the same
dose (Table 3). The effect ofHCB on spleen
weight was also higher in athymic rats than in
euthymic rats exposed to the same dose of
HCB (Table 3). Morphometric analysis of
spleen sections ofcontrol and HCB-exposed
athymic and euthymic rats was performed to
determine the effect of HCB on different
spleen compartments. Relative areas ofthe
white pulp andperiarteriolar lymphatic sheath
(PALS) were measured with an automated
image analyzer. These measurements were
used to estimate the absolute total weight of
red pulp, PALS, marginal zones, and follides
(Table 3). HCB induced a significant increase
Table 3. Effects of 6-week oral exposure to 450 mg/kg hexachlorobenzene on body weight; absolute and relative
liver and spleen weight; absolute and relative estimated red pulp; PALS; and follicles and marginal zones weight in
euthymic and athymic Wistar rats.





Control 242 ± 10 9.52± 0.41 421 ± 22 277 ±30 42±6 102±23
450 mg/kg HCB 202± 22** 13.26 ± 1.32*** 584± 75*** 405± 64*** 44± 13 134± 23*
Athymic
Control 175±21 6.47±0.94 444±49 319±34 11±3 114±18
450 mg/kg HCB 122 ± 7*** 10.77 ± 0.82*** 573 ± 89* 452± 101** 9±4 112±38
Organ-to-body weightratiosd
Euthymic
Control 3.94±0.28 174±11 115±13 17±3 42±9
450 mg/kg HCB 6.59 ± 0.47*** 289± 19*** 200± 14*** 22±6 67± 13**
Athymic
Control 3.68±0.21 253±6 182±17 6±2 65±5
450 mg/kg HCB 8.88± 0.88*** 473± 80*** 374± 90*** 8± 3 91 ± 27*
Abbreviations: HCB, hexachlorobenzene; PALS, periarteriolar lymphatic sheath; SD, standard deviation. Bodyweight and liverweight
± SD are given in grams. "Spleen weight ± SD is given in milligrams. cRelative areas of the white pulp and PALS were measured by
using an automated image analyzer and these measurements were used to calculate the weight ofthe red pulp, PALS, follicles, and
marginal zones. d(Milli)gram per 100 g body weight. Asterisks denote significance from the corresponding control group (*p< 0.05;
**p<0.01; ***p<0.001, respectively), n =6 pertreatment group.
in absolute red pulp weight in both athymic
and euthymic rats. A significant increase of
absolute weight offollides and marginal zones
was observed only in euthymic rats exposed to
HCB, leading to the conclusion that the
effects of HCB on splenic white pulp are
thymus dependent (67). This all-or-none
conclusion may be questioned, as athymic rats
showed a significant decrease in body weight
and a more marked increase ofliver weight
compared to euthymic rats exposed to the
same dose of HCB. This points at a higher
toxicity ofHCB in athymic rats compared to
euthymic rats and thus the possibility of
stress-induced effects on the splenic white
pulp in athymic rats. Therefore, we also com-
pared the effects ofHCB on the estimated rel-
ative (organ-to-body) weight of splenic
compartments (Table 3). Then a significant
increase ofestimated relative weight ofmar-
ginal zones and follicles was also observed in
athymic rats exposed to HCB. This effect on
splenic white pulp in athymic rats, however,
was disproportional to the more marked rela-
tive liver weight increase and increase ofred
pulp observed in athymic rats compared to
euthymic rats. On the basis ofthis study, we
concluded that thymus-dependent T cells are
not required for HCB-induced hyperplasia of
marginal zones and follides, but that T cells
may enhance the effect ofHCB on splenic
white pulp in euthymic rats. Recendy, we fur-
ther investigated the effects of HCB on
splenic red pulp ofathymic and euthymic
WAG/Rij rats. Histology showed increased
extramedullary erythropoiesis and myelo-
poiesis; presence ofactivated cells, mainly
macrophages and fibroblasts, in the red pulp;
and increased numbers ofgranulocytes in the
venous sinusoidal network bordering the
marginal zones (Figure 1).
The effect ofHCB on two models of
autoimmune disease in the Lewis rat. To
study the effect of HCB on thymus-
dependent autoimmune diseases in the rat,
two experimental models ofautoimmune dis-
ease in the rat, adjuvant arthritis (AA) and
experimental allergic encephalomyelitis
(EAE), were used (68). Male Lewis rats 3-4
weeks ofagewere orallyexposed to diets con-
taining 0, 50, 150, or 450 mg HCB/kg diet.
After 6 weeks of HCB exposure, rats were
injected either a) intradermally via the tail
base with Freund's complete adjuvant
([FCA], a mixture ofmineral oil, a detergent,
and dead Mycobacterium tuberculosis H37Ra)
to induceAA, or b) subcutaneously in the left
hind footpadwith guinea pig myelinwith the
same FCA to induce EAE. The development
ofEAE was investigated daily and the degree
of paralysis was rated 0 (no paralysis), 1
(paralysis of one hind limb), 2 (complete
hind limb paralysis), 3 (paraplegia), and 4
(death) per rat. The onset ofarthritic lesions
in the joints was investigated every other day
and the severity was rated 0 (no observable
lesion or swelling) to 4 (severe swelling and
redness) per paw, yielding a maximal possible
score of16.
Figure 2showsthatHCBdosedependendy
suppressed the induction ofAA. Rats exposed
to the high dose of450 mg/kg HCB failed to
developAA, although one rat showed inflam-
mation ofthe joint ofone leg at the end of
the study. In contrast, oral exposure to HCB
dose dependently enhanced the severity of
EAE. Whereas rats that received 0, 50, and
150 mg/kg HCB recovered spontaneously
from the active disease, those that received
450 mg/kg HCB developed chronic progres-
sive EAE and died. The mechanism underly-
ing this contradictory effect ofHCB on these
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two models of autoimmune disease in the
Lewis rat is unknown, as both models require
specific T-helper 1 cell involvement. A possi-
ble explanation may lie in an effect ofHCB
on other cells or processes involved in these
autoimmune models. For example,
macrophages are important effector cells
involved in the development ofclinical signs
ofEAE (69), and recently it has been shown
that macrophage-derived IL-12 may con-
tribute to exacerbation and relapse of EAE
(70). The pathogenesis ofAA involves many
cell types. Recently it was shown that infiltra-
tion of activated neutrophilic granulocytes
into the joint is an important step in the
development ofrheumatoid arthritis (71).
HCB-inducedautoantibodies. According
to recent studies, the immunostimulatory
effects ofHCB in the rat may be related to
autoimmunity. Wistar rats orally exposed to
HCB showed increased IgM but not IgG
antibodies to several autoantigens such as
single-stranded DNA, native DNA, rheuma-
toid factor, and phosphatidylcholine (61). In
another study, Brown Norway, Lewis, and
Wistar rats orally exposed to HCB showed
IgM autoantibodies against single-stranded
DNA (72). Although the autoantibodies are
naturally occurring IgM autoantibodies of
low affinity and known to have little patho-
genicity (73), further studies have investi-
gated whether these autoantibodies are
involved in the induction of inflammatory
skin and lunglesions in the rat.
HCB-Induced Immunomodulation
inMice
Loose et al. (74) showed that male BALB/c
mice that received 167 mg HCB per kg diet
for over 6 weeks displayed no effects on lung,
thymus, and spleen weights and histology,
whereas liver cell hypertrophy was present. In
the same study HCB induced a suppression of
the thymus-dependent humoral immunity, as
measured by the response to sheep red blood
cells, in the absence ofalterations of total
serum IgM and IgG values. In another study,
Loose and co-workers (75) showed impaired
host resistance in BALB/c mice exposed to dif-
ferent concentrations of HCB over 3-10
weeks. Increased susceptibility to endotoxin
(Salmonella typhosa) and significantly sup-
pressed resistance to infection with malaria
(Plasmodium berghez) and Leishmania were
noted. In tumor susceptibility studies, differ-
ent strains of mice orally exposed to HCB
showed a dose-related decrease oftheir resis-
tance to challenges with syngeneic tumor cells,
as measured by decreased survival times, prob-
ably due to a significant reduction oftumori-
cidal activity ofcytotoxic macrophages in the
spleen (76). More recently, decreased resis-
tance to mouse hepatitis virus was demon-
strated in BALB/c mice exposed to HCB,
Figure 1. Representative spleen sections from a control rat (A) and from rats fed 450 mg hexachlorobenzene
(HCB)/kg diet for 4 weeks (B,C). The different compartments of the white pulp are indicated by P, periarteriolar lym-
phatic sheaths; F, follicles; and MZ, marginal zones. Note the hyperplasia of the white pulp, especially of the mar-
ginal zone, and the extramedullary hemopoiesis (arrowheads) in the red pulp of HCB-treated rats. Panel C shows a
higher magnification of the splenic red pulp from an HCB-treated rat. Note the abundant presence of polymorphonu-
clear granulocytes (arrows) and normoblasts and myeloblasts (arrowheads). Hematoxylin and eosin, magnification
A, Bx 100; Cx 400.
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Figure 2. The effect of hexachlorobenzene (HCB) on two experimental models of autoimmune disease in the Lewis rat. Male Lewis rats 3-4 weeks of age were orally exposed to
diets containing 0, 50, 150, or 450 mg HCB/kg diet. After 6 weeks of exposure, the effect of HCB on the development of adjuvant arthritis (A) and experimental allergic
encephalomyelitis (B) was investigated.
whereas resistance to mouse cytomegalovirus
and a pneumonia-causing virus was not
impaired. This has been explained by the
HCB-induced decrease ofphagocytic and
detoxifying capacity of Kupffer cells in the
liver, resulting in an enhanced infection of
hepatocytes by mouse hepatitis virus (77).
Decreased phagocytic and detoxifying capac-
ity of Kupffer cells could also explain the
HCB-induced increased susceptibility to
endotoxin (77). Exposure ofC57BL/6 mice
to 167 mg HCB/kg body weight for 3, 6, or
13 weeks showed no effect on the graft-
versus-host activity when spleen cells ofthese
HCB-exposed mice were inoculated into
neonatal BDF1 mice. On the contrary, graft-
versus-host activity was significantly
depressed after 37 weeks ofexposure to HCB
(78). In another study [quoted in IARC
(79)] in male C57BL/6 mice, oral exposure
to HCB increased several parameters ofhost
resistance. Oral exposure to 150 mg/kg HCB
resulted in an increased resistance to
encephalomyocarditis infection and increased
resistance to progressive growth ofmethylchol-
anthracene-induced sarcoma, whereas there
was no significant effect ofHCB on resistance
to Moloney sarcoma virus-induced tumor
cells. In the same study, 15 mg/kg HCB
increased cytotoxic lymphocyte activity gen-
erated in vivobyinoculation ofC57B1/6 mice
with DBA/2 mastocytoma, increased P815
tumor cells and was assessed in vitro in a
51Cr-release cytotoxicity assay. No effect of
HCB was observed on the phagocytic activity
ofperitoneal macrophages (79). Barnett and
co-workers (80) studied the effect of in utero
HCB exposure on the developing immune
response ofBALB/c mice. Mice were exposed
daily to 0, 0.5, or 5 mg HCB/kg maternal
body weight; at 45 days of age selected
immune functions were tested in the off-
spring. A severely decreased delayed-type
hypersensitivity response to oxazolone was
observed in animals exposed to 0.5 and
5 mg/kg HCB. The mixed lymphocyte
responses ofspleen cells from control BALB/c
mice and BALB/c mice that received HCB
was measured by culturing the cells in the
presence of mitomycin C-treated allogenic
C57BL/6 spleen cells for 72 hr. The mixed
lymphocyte response of mice that received
5 mg/kg HCB was significantly decreased,
whereas blastogenic responses of isolated
spleen cells to ConA, phytohemagglutin, and
LPS were unchanged. In the same study,
increased numbers ofT cells and decreased




Female rhesus monkeys that received graded
doses ofHCB (8, 32, 64, or 128 mg/kg per
day) via gastric instillation showed histologic
changes in the thymus. These changes con-
sisted ofa reduction or absence ofindividual
lobules and hyperplasia of reticular cells,
macrophages, and plasma cells in the
medulla (36).
In beagle dogs administered different
doses of 99% pure HCB (1, 10, 100, or
1,000 mg/day in a gelatin capsule) during
1 year, significant neutrophilia was observed
after several weeks in most dogs receiving 100
and 1,000 mg/day. Hyperplasia ofthe gastric
lymphoid tissue was also frequently observed
in dogs ofall dose groups. Moreover, in the
high-dose group, 33% ofthe dogs displayed
arteritis-periarteritis ofsmall arteries and
arterioles affecting multiple organ sites (81).
This severe arteritis resembled the earlier
described vasculitis in livers ofrats exposed to
HCB ofunknown purity (48) and had many
characteristics suggesting hypersensitivity
angitis or polyarteritis; however, there were
no indications for the presence ofelevated
serum antibodylevels.
Recently, a study in 51-66 workers occu-
pationally exposed to HCB showed impaired
functions of neutrophilic granulocytes
compared to neutrophilic granulocytes of a
control group of48 nonexposed age- and
sex-related individuals. Neutrophils from
HCB-exposed individuals showed a signifi-
cantly reduced chemotaxis as well as asignifi-
cant reduced respiratory burst activity, as
measuredby nitroblue tetrazoliumdye reduc-
tion. However, in the HCB-exposed workers,
there was no correlation between the length
ofHCB exposure or HCB concentrations in
blood and the changes in the neutrophil
functions (82). In the same group ofworkers,
increased serum IgM and IgG levels were
observed, whereas serum IgA levels were nor-
mal (83). In asubsequentstudyphagocytosis
and killing of Candida albicans and Candida
pseudotropicalisbypolymorphonuclear granu-
locytes from the HCB-exposed workers or
nonexposed control individuals were com-
pared. HCB showed no effect on phagocyto-
sis, whereas lysis of C. albicans and
C pseudotropicalis was significantly decreased
in the HCB-exposed group compared to the
control group. As observed in the previous
study, there was no correlation between the
length of HCB exposure, blood levels of





The role ofmetabolism. In the Wistar rat,
HCB feeding induces inflammatory skin and
lung changes (59-62). Several studies inves-
tigated whether the parent compound HCB
itself or its reactive metabolites are involved
in the induction ofimmune effects and skin
and lung lesions. One of the first studies
investigated the involvement ofporphyrins
in the induction of skin lesions by HCB
(62,85), as these skin lesions have been
attributed to dermal accumulation and sub-
sequent photochemical activation of por-
phyrins (52). Coadministration of the
P450IIIA1/2 inhibitortriacetyloleandomycin
to HCB-treated Wistar rats resulted in a
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strong reduction of hepatic porphyria and
the formation of the oxidative metabolites
PCP and TCHQ. In contrast, autoantibody
levels and induction ofskin lesions remained
unaffected (Table 4). It was concluded from
this study that the oxidative metabolites of
HCB (i.e., PCP, TCHQ) and HCB-induced
porphyria are not involved in the
immunomodulating effects and induction of
skin lesions by HCB (62,85). The suggestion
that skin lesions in the rat are not due to
phototoxicity ofdermal accumulated por-
phyrins was confirmed by the absence ofpor-
phyrin fluorescence in lesional and
nonlesional skin of HCB-treated rats.
Therefore it is possible that rats develop the
juvenile, porphyria-independent form of
HCB-induced skin lesions as observed in
children under 4 years ofage in the Turkish
HCB poisoning accident (72).
In another study the role ofthe mercap-
turic acid biotransformation pathway in the
HCB-induced inflammatory skin and lung
lesions was investigated (86). This biotrans-
formation pathway, resulting in the forma-
tion ofthe urinary end product PCP-NAC,
is the major route ofmetabolism in female
Wistar rats exposed to HCB (85). Moreover,
cumulative urinary levels ofPCP-NAC from
Wistar rats orally exposed to HCB correlated
significantly with serum IgM, IgA, and IgM
anti-bromelain-treated red blood cells (62).
Brown Norway rats exposed to penta-
chloronitrobenzene, a compound metabo-
lized via the same (mercapturic acid)
biotransformation pathway as HCB (18,19),
showed no effects on spleen, skin, or lung.
This indicates that this route ofmetabolism
ofHCB is not involved in the induction of
splenomegaly and inflammatory skin and
lung lesions. Therefore, it is concluded that
either the parent compound HCB or yet
unidentified metabolites are involved in the
inflammatory effects ofHCB (86).
Strain dependency ofHCB-induced
skin and lungpathology. In a recent study
we investigated the involvement of the
immune system in the induction ofskin and
lung lesions by HCB (72). We fed three rat
strains (i.e., Brown Norway, Lewis, and
Wistar, known to react very diversely to
immunomodulating compounds) diets con-
taining different doses ofHCB for 4 weeks.
Table 4. The role of metabolism in the target organ tox-
icity of hexachlorobenzene in the rat.
Hepatic Immune Skin
porphyria effects lesions
HCB + + +
HCB +TA0a - + +
Abbreviations: HCB, hexachlorobenzene; TAO, triacetyloleando-
mycin. TAO is a selective inhibitor of P450111al/2. Data from
Van Ommen et al. (20), Den Besten et al. (85), and Schielen
et al. 162).
Skin lesions were scored during the exposure
according to time ofonset, incidence, and
severity. After 4 weeks of exposure,
histopathology ofskin and lung as well as var-
ious parameters ofimmunomodulation were
examined. There was a marked strain-
dependent induction ofskin lesions far more
prominent in Brown Norway rats than in
Lewis and Wistar rats. Skin lesions became
macroscopically manifest in the head and
neck region of Brown Norway, Lewis, and
Wistar rats after 15, 17, and 24 days ofexpo-
sure, respectively. Skin lesions ranged in
severity from slight redness to large hemor-
rhagic lesions with exudative crusts and were
histologically characterized by loss or hyper-
plasia ofthe epidermis and deep dermal acti-
vation ofvessels. An inflammatory infiltrate
ofmainly eosinophilic granulocytes in Brown
Norway and mononudear cells in Lewis and
Wistar rats was observed in the deep dermis.
Hyperplasia ofthe epidermis, activation of
deep dermal vessels, and inflammatory infil-
trates were also observed in macroscopically
intact skin ofHCB-exposed rats, although
they appeared less severe compared to
changes in lesional skin. In the Brown
Norway rat, skin lesions correlated with all
measured parameters ofimmunomodulation
(Table 5) such as increased lymph node
weights; activation of high endothelial
venules; increased serum IgM, IgG, and IgE
levels; and increased single-stranded DNA-
specific IgM. In the Lewis rat, skin lesions
correlated only with serum IgE and single-
stranded DNA-specific IgM, whereas in
Wistar rats no significant correlation
between skin lesions and parameters of
immunomodulation was observed. This is in
contrast with earlier findings of Schielen
et al. (62). They demonstrated a significant
correlation between serum IgM levels and
severity ofskin lesions in female Wistar rats
fed 300 mg HCB/kg diet, but this may be
related to the longer exposure period of 13
weeks. HCB induced inflammatory lung
lesions in all rat strains that consisted offocal
accumulations of alveolar macrophages and
proliferation ofthe endothelium oflung ves-
sels, which were attended by a perivascular
infiltrate (60,63,87,88). The induction of
inflammatory lung lesions by HCB appeared
hardly strain dependent and was slightly
stronger in Lewis rats compared to Brown
Norway and Wistar rats. The perivascular
infiltrate varied strain dependently and con-
sisted ofmainly eosinophilic granulocytes in
Brown Norway rats and mononuclear cells in
Lewis and Wistar rats. In contrast to skin
lesions, no correlation was found between
inflammatory lung lesions and the assessed
parameters ofimmunomodulation. From this
study we concluded that the HCB-induced
skin and lung lesions probably have different
etiology. Pronounced strain differences in
skin lesions as well as the positive correlation
with several immune parameters indicate a
specific involvement ofthe immune system in
the developmentofskin lesions.
The roleofautoantibodies. To investigate
whether deposition ofautoantibodies in the
skin is involved in the induction of skin
lesions, skin of control and HCB-exposed
rats was incubated with a fluorescein isothio-
cyanate (FITC)-labeled mouse-anti-rat
kappa-chain antibody (MARK-1) (MARK-
1-FITC). In addition, to detect serum
autoantibodies directed to skin proteins, skin
of control Brown Norway rats, as well as
nonlesional and lesional skin ofHCB-treated
Brown Norway rats, was incubated with
either control serum or serum of Brown
Norway rats exposed to HCB. To detect
binding ofautoantibodies, sections were sub-
sequently incubated with MARK-1-FITC.
As a positive control, kidney sections ofa rat
Table 5. Summary and gradation ofthe effects of hexachlorobenzene in Brown Norway, Lewis, andWistarrats.ab
Brown Norway Lewis Wistar
(450 mg/kg) (450mg/kg) (900mg/kg)
Parameters ofgeneral toxicity
Bodyweight increase + + +
Liver effects ++ ++ ++
Parameters of immunomodulation
Increase in
Spleen weight ++ + +
PLN weight ++ + +
Lymph node ++ ++ ++
Serum 1gM levels ++ ++ ++
Serum lgG levels +- -
Serum IgE levels +++
Serum IgM anti-single-stranded DNA ++ ++
Inflammatory lesions
Gross skin lesions +++ +
Lung effects ++ ++ +
Abbreviations: HEV, high endothelial venules; PLN, popliteal lymph node; ssDNA, single-stranded DNA.'Gradation scale: -, no
increase; ±, minimal; +, slight; +±, moderate; ++, marked; +++, very severe.bReprinted from Michielsen et al. (721, with permission of
Academic Press.
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with experimentally induced immunocomplex-
mediated Heymann nephritis (kindly
supplied by E. de Heer, Leiden, The
Netherlands) were incubated with MARK-1-
FITC. No fluorescence above background
was observed in the skin ofcontrol or HCB-
treated Brown Norway rats (either incubated
or not incubated with serum of control or
HCB-treated rats), indicating that there were
no serum autoantibodies to skin proteins and
no deposited immune complexes in skin.
This contradicts our earlier results obtained
with the enzyme-linked immunosorbent assay
(ELISA) that showed presence ofIgM anti-
bodies against single-stranded DNA and
double-stranded DNA in sera of HCB-
exposed rats (72) but can be explained by the
weak affinity ofthese IgM autoantibodies.
Whereas ELISA is a very sensitive method
and detects antibodies with high and low
affinities for the antigen tested, immuno-
histochemistry detects only the antibodies,
which have a high affinity and therefore are
pathogenic. Binding ofthese autoantibodies
was not observed, indicating that autoanti-
bodies are probably not involved in the
induction ofskin lesions byHCB.
Thymus dependency ofHCB-induced
skin andlungpathology. In another study
we investigated the role ofthymus-dependent
T cells in HCB-induced inflammatory skin
and lung lesions. Brown Norway rats were
depleted ofT cells by adult thymectomy fol-
lowed by lethal irradiation and bone marrow
reconstitution (89). The resulting T-cell
depletion was analyzed by fluorescence-
activated cell sorter analysis and immuno-
histochemistry and appeared strong. Skin
lesions appeared slower and at a lower inci-
dence in T-cell-depleted Brown Norway rats
orally exposed to 450 mg/kg HCB in the diet
than in normal Brown Norway rats exposed
to the same dose. At the end ofthe 4-week
exposure, however, incidence and severity of
skin lesions were comparable as well as the
histopathologic changes in lesional and non-
lesional skin ofHCB-treated normal and T-
cell-depleted Brown Norway rats. HCB
induced quantitatively and qualitatively com-
parable inflammatory lung lesions in normal
and T-cell-depleted Brown Norway rats as
well as in athymic and euthymic WAG/Rij
rats that were exposed to HCB. An earlier
study with male athymic and euthymic
Wistar rats exposed to 450 mg/kg HCB over
6 weeks demonstrated that the induction of
inflammatory lung lesions by HCB is thymus
independent (67). Thus, studies with
T-cell-depleted Brown Norway rats con-
firmed earlier conclusions that the induction
oflung lesions by HCB is thymus indepen-
dent. In addition, thymus-dependent T cells
are not likely to be required for the induction
of skin lesions by HCB in the rat, although
T cells enhance the rate ofinduction and pro-
gression ofskin lesions. Because the T-cell
depletion appeared strong and resulted only
in a slight difference in the rate ofinduction
and progression ofskin lesions, we concluded
that this immunopathology is probably not
due to binding of HCB or its reactive
metabolites to macromolecules ofthe body.
Binding oflow molecular weight chemicals to
macromolecules ofthe body followed by sub-
sequent T- and B-cell stimulation is consid-
ered to be the mechanism involved in most
allergic and autoimmunogenic low molecular
weight chemicals (90,91). A thymus-
independent etiology ofskin and lung lesions
is remarkable, as HCB strongly modulates
T-cell-mediated immune parameters but is
confirmed by studies described earlier in this
section that failed to demonstrate the pres-
ence of autoantibodies in nonlesional and
lesional skin ofHCB-treated Brown Norway
rats. However, several mainly inert chemicals,
e.g., crystalline silica, are able to induce
autoimmunelike effects by the nonspecific
generation ofcytokines and release ofreactive
oxygen and nitrogen species by granulocytes
and macrophages (92). Recently we demon-
strated the presence oflarge numbers ofacti-
vated CD8+ macrophages in nonlesional and
especially lesional skin of HCB-treated
Brown Norway rats (89). These CD8-
expressing macrophages in the rat are able to
produce and release nitric oxide upon stimu-
lation (93,94). Stimulation of these
macrophages to release nitric oxide or other
potent mediators could account for the
observed pathology and lead to chronic
inflammation. In addition, eosinophilic gran-
ulocytes that are frequently observed in the
lung of HCB-treated highly susceptible
Brown Norway rats are also very potent effec-
tor cells. Besides their beneficial properties in
host defense, eosinophil degranulation or
cytolysis ofeosinophils can become detrimen-
tal to the host and contribute to local pathol-
ogy at the site of inflammation (95).
Therefore, involvement ofthese granulocytes
and macrophages in the induction of skin
and lung lesions by HCB needs further
investigation.
Conclusion
It is clear from many studies in laboratory
animals that HCB is an environmental chem-
ical with immunotoxic properties
(59-61,63). Recently, immune effects such as
increased serum IgM and IgG levels and
impaired functions ofneutrophilic granulo-
cytes have been reported in workers occupa-
tionally exposed to HCB (82-84). In the rat,
HCB mainly induces stimulation ofparame-
ters of immune function, whereas in the
mouse, most assessed immune function para-
meters are suppressed by HCB (63,74-80).
Oral exposure ofrats to HCB elevates serum
IgM antibodies to several autoantigens
(61,72) and differently modulates two experi-
mental models ofautoimmune disease, AA
and EAE (68). Moreover, an (auto)immune
etiology is also conceivable for the enlarged
thyroid, arthritic lesions of the hands, and
dermatologic effects in patients ofthe acci-
dental poisoning in Turkey, which persisted
25 years later (58). The mechanism bywhich
HCB affects skin, lung, and immune system
is still unclear. HCB-induced lung lesions are
strain- and thymus-independent and do not
correlate with parameters ofimmunomodu-
lation (72,89). Therefore, an autoimmune or
allergic etiology resulting from binding of
HCB or metabolites thereof to macromole-
cules ofthe body is probably not involved in
HCB-induced lung lesions. Induction ofskin
lesions in the rat is highly strain dependent
and correlates with several parameters of
immunomodulation (72). Thymus-
dependent T cells are not likely to be
required for the induction ofskin lesions but
enhance the rate ofinduction and progression
of the lesions in the Brown Norway rat.
Moreover, in the skin of HCB-treated rats
there was no deposition of immune com-
plexes, and no autoreactive antibodies to skin
proteins could be detected in the serum of
HCB-treated rats. Therefore, we concluded
that the induction ofskin and lung lesions by
HCB is probably not due to binding ofHCB
or its reactive metabolites to macromolecules
ofthe body. Such a thymus-independent eti-
ology ofthe skin and lung lesions is remark-
able, as HCB strongly modulates
T-cell-mediated immune parameters
(59,60,68). This points at a very complex
mechanism and possible involvement ofmul-
tiple factors in HCB-induced immunopathol-
ogy. The presence of large numbers of
activated macrophages in the skin and large
numbers ofmacrophages and polymorphonu-
clear cells in the lung of HCB-exposed
patients suggests that these cells may be
involved in the induction ofskin and lung
lesions. Whether the HCB-induced
immunopathology is associated with effects of
HCB on (eosinophilic) granulocytes and
macrophages needs further investigation.
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